Skip to main content

Olukotun Adeoye Y

In the past year, 2 open-market sale filings worth $850.5K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$850.5K
2 filings
Net
−$850.5K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Olukotun Adeoye Y as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ARWR Arrowhead Pharmaceuticals, Inc.

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2021 (view filing)Sep 131 dayOlukotun Adeoye YDirectorSSale−5.00K$63.76−$318.8K−35.7%9.00K after2 lots
Jan 4, 2022 (view filing)Jan 31 dayOlukotun Adeoye YDirectorSSale−4.05K$64.75−$262.2K−45.0%4.95K after3 lots
Mar 6, 2023 (view filing)Mar 33 daysOlukotun Adeoye YDirectorSSale−11.3K$32.65−$370.6K−59.1%7.87K after
Dec 30, 2024 (view filing)Dec 273 daysOlukotun Adeoye YDirectorSSale−2.85K$20.00−$57.0K−7.2%36.7K after10b5-1
Jan 27, 2025 (view filing)Jan 234 daysOlukotun Adeoye YDirectorSSale−959$21.00−$20.1K−2.6%35.8K after10b5-1
Dec 23, 2025 (view filing)Dec 194 daysOlukotun Adeoye YDirectorSSale−10.0K$67.66−$676.6K−22.9%33.6K after3 lots10b5-1
Aug 20, 2026 (view filing)5:25 PM ETAug 182 daysOlukotun Adeoye YDirectorSSale−2.00K$86.96−$173.9K−6.0%31.6K after